Clinical Trials Logo

Personality Disorders clinical trials

View clinical trials related to Personality Disorders.

Filter by:

NCT ID: NCT05428462 Completed - Clinical trials for Borderline Personality Disorder

Effectiveness of a One-day Psychoeducation Program on Internalized Stigmatization for BPD Patients

EDUC-BPD
Start date: January 1, 2021
Phase:
Study type: Observational

Education day on borderline personality disorder (BPD), including a transmission of current scientific knowledge on the disease. A dimensional understanding of BPD is delivered as well as disidentification of oneself to the symptoms of borderline personality disorder (Ducasse 2020 Eur Arch Psychiatry Clin Neurosci). The main objective is to evaluate the impact of borderline education day on self-stigma.

NCT ID: NCT05418270 Completed - Aging Clinical Trials

Anorexia and Personality Traits in Elderly Individuals

APETI
Start date: June 2, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate the relationship between age-related anorexia and personality traits in elderly individuals with comorbidities.

NCT ID: NCT05404035 Recruiting - Relatives Clinical Trials

"Family Connections" for Caregivers of People With Eating Disorders and Personality Disorders.

FC-ED&PD
Start date: May 23, 2022
Phase: N/A
Study type: Interventional

The aim of our study is to verify the efficacy of the Family Connections intervention for relatives of people diagnosed with eating disorders and personality disorders in a randomized control trial with a Spanish participants.

NCT ID: NCT05399498 Recruiting - Clinical trials for Major Depressive Disorder

Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

Start date: November 1, 2023
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to evaluate the safety and efficacy of psilocybin in adults with major depressive disorder (MDD) and borderline personality disorder (BPD).

NCT ID: NCT05398627 Recruiting - Clinical trials for Borderline Personality Disorder

Neurofeedback for Borderline Personality Disorder

Start date: September 2, 2022
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as an intervention for borderline personality disorder.

NCT ID: NCT05397613 Enrolling by invitation - Clinical trials for Posttraumatic Stress Disorder

STAIR for Trauma and Emotion Dysregulation

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

This study will examine the impact of Skills Training in Affective and Interpersonal Regulation (STAIR) group, using self-report measures, on Posttraumatic Stress Disorder (PTSD), emotional dysregulation, borderline personality disorder symptoms, global psychopathology, and access to quality mental health care. Aims include assessing the feasibility of STAIR, reducing patients' trauma and emotion dysregulation symptoms, examining whether STAIR may be used as an alternative to DBT for patients on the DBT, and improving patient satisfaction and clinic efficiency

NCT ID: NCT05383300 Completed - Clinical trials for Antisocial Personality Disorder

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

OXYASP
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

A pharmacoimaging study of oxytcoin in antisocial personality disorder and psychopathy

NCT ID: NCT05381649 Recruiting - Clinical trials for Emotionally Unstable Personality Disorder, Borderline Type

Empathy Anomalies in Emotionally Unstable (Borderline) Personality Disorder

Start date: November 20, 2022
Phase:
Study type: Observational

Emotionally unstable (borderline) personality disorder (BPD) is characterised by changeable and extreme emotions and difficulty maintaining relationships. It is often associated with self-harm. Empathy has two components; cognitive empathy (imagining someone else's thoughts and feelings) and emotional empathy (the reciprocal emotional response). People with BPD score low on cognitive empathy but high on emotional empathy. This suggests that they do not easily understand other peoples' perspectives, but their own emotions are very sensitive. This is important because it could align BPD with other neurodiverse conditions. This study will use a computer-based empathy test and short questionnaires to investigate whether empathy changes during the course of BPD, and if the severity of empathy impairments correlate with severity. The tests are the multifaceted empathy test (MET) and the questionnaire of cognitive and affective empathy (QCAE). The MET requires participants to look at photographs of emotive faces, then choose the most appropriate adjective. It takes 30 minutes to complete. The QCAE asks 31 questions like 'it is hard for me to see why some things upset people'. Participants will be invited to join the study when they are diagnosed with BPD. Severity will be measured with the Borderline Symptom List 23, a disability questionnaire, and the number of self-harming episodes per month, the number of hospital assessments per month and the number of hospital admissions per month. Short NHS questionnaires of anxiety, depression and mood will also be completed, along with short reading test. About 30 participants will be assessed 4 times over 2 years.

NCT ID: NCT05358925 Recruiting - Clinical trials for Borderline Personality Disorder

Psychoeducational Videos and Digital Assessments for BPD

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

In this study, 100 adults who were recently diagnosed with borderline personality disorder (BPD) will be randomized to either receive educational videos about BPD or educational videos about other topics. All participants in both conditions will complete daily surveys about their emotions and social interactions, and they will respond to surveys and complete cognitive tests at 4 different time points. Some participants will receive feedback about their cognitive test performance, and others will not. The investigators are interested in learning about how accurate education about BPD and enhanced knowledge about cognitive abilities might help people manage their BPD symptoms. The investigators expect that participants who received psychoeducation about BPD will have lower levels of BPD and depressive symptoms than other participants, and that participants who received feedback on their cognitive tests will also have lower symptoms.

NCT ID: NCT05357521 Completed - Clinical trials for Borderline Personality Disorder

Interplay Between Oxytocin and Cortisol During Stress in Borderline Personality Disorder

OXT-CORT-BPD
Start date: March 1, 2022
Phase:
Study type: Observational

This study aims to determine the feasibility and preliminary data on the interaction between oxytocin and cortisol during stress in borderline personnality disorder.